Histo - Breast Flashcards

1
Q

Painful, red breast and fever. Lactation and breast feeding. Histo shows neutrophil infiltration

A
Acute mastitis
Staph aureus
Rx
Continue lactation - stop abscess
Abx and drainage if nec
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Smoker, mastitis

Histo shows keratinising squamous epithelium

A

Periductal mastitis

Benign, no malignant potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 children, 50 years old, thick white nipple secretions. Histo shows granulomatous inflammation and dilation

A

Mammary Duct Ectasia

Benign, no malignant potential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Coding of breast lump aspirates

Pathologist says grade is C3, what do you do?

A

Refer for core biopsy + histology

C1 = inadequate 

C2 = benign  

C3 = atypia, probably benign 

    Probably chase and do a core biopsy + histology 

C4 = suspicious of malignancy 

C5 = malignant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Had trauma to the chest. Presents with a breast mass: hard, firm lump.

Cytology: inflammatory cell infiltrates into adipose tissue, multinucleate giant cells (clumped macrophages)
A

Fat Necrosis

Inflammatory reaction to damaged adipose tissue e.g. after trauma, surgery, radiotherapy 

Benign condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Breast lumpiness in cycle with periods. Histo shows calcifications

A

Fibrocystic disease

Group of alterations in the breast leading to fibrosis and cystic changes

Normal, albeit exaggerated, response to hormonal changes

Very common, no malig risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Painless, firm, solitary, mobile, slowly growing lump in the breast of a woman of child-bearing years

Cytology: mix of glandular cells ("epithelial") and proliferating stromal cells ("fibro")
A

Fibroadenoma

‘Breast mouse’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Similar to fibroadenoma presentation

Cytology: Cells are overlapping due to excess glandular and stromal proliferations

“Leaf-like, broad swaths of stroma, surrounded by glandular epithelial cells”

Stroma begins to appear blue due to overgrowth/stromal cellularity

A

Phyllodes tumour

A group of potentially aggressive fibroepithelial neoplasm

“Leaf-like” by name, and by shape

Uncommon

Usually seen in women in their 50s.

Vast majority are benign, but small majority are aggressive, therefore excision is necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

A benign tumour arising from the duct system of the breast. Bloody discharge.

Pedunculated on a stalk, with a fibrovascular core

Arise within small terminal ductules (peripheral papillomas) or large lactiferous ductules (central papillomas)

A

Intraductal papilloma

Think of this like you would a polyp

Common, seen mostly in ages 40-60
Central papillomas: present with nipple discharge

Peripheral papillomas: can remain silent if small
Excision of involved duct is curative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A benign sclerosing lesion characterised by central zone of scarring, surrounded by radiating zone of proliferating glandular tissue

A

Radial scar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Proliferative breast disease, what is interesting with how the duct presents?

A

Doesn’t necessarily have a lesion unless calcified. Luminal change is most obvious sign.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lumen are typically irregular and oblong.

A

Usual epithelial hyperplasia

Marker for ↑risk of malignancy (1.5 to 2x depending on severity of hyperplasia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lumen are typically round and punched-out from the surrounding tissue, which is a marker for atypical disease

A

Flat epithelial atypia (FEA)/Atypical ductal carcinoma

Evidence suggests that FEA may represent the earliest morphological precursor to low-grade ductal carcinoma in-situ 

4x relative risk of developing cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In-situ lobular neoplasia

A

Increased risk of invasive breast cancer

Relative risk of 7-12 times
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Calcification. 10% might have lump or discharge

Histology

Punched-out, well-circumscribed lumen of the duct 
Overlapping, rapidly developing cells 
Calcifications 

Histology (high-grade)

Large, pleomorphic cells which completely occlude the distended duct's lumen
A

Ductal carcinoma in situ (DCIS)

the CALCIFICAITON is the giveaway

10% - lump, discharge, eczematous change in nipple (paget’s disease of nipple)

Complete excision or mastectomy, depending on size.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Invasive carcinoma

Pleomorphic cells. Large, nucleated, ↑nuclear:cytoplasm ratio.

Invading stroma beyond the ducts

A

Ductal

Large cells, abnormal, variable size. Lobular is more linear and smaller and similar size.

17
Q

Invasive carcinoma

Tend to have linear arrangement

Tend to be less horrific looking, with monomorphic
(similar sized) cells

Indian file pattern: single line of monomorphic cells

A

Lobular

Linear whilst ductal is variable

18
Q

Little tubules which are round and elongated, where the cancer invades into

A

Tubular

19
Q

Mucin-containing cells

A

Mucinous

20
Q

What is the most important prognostic factor?

A

Invasion into the apical lymph nodes - this is why you always check these LN on breast exam

21
Q

Sheets of atypical cells with prominent lymphocytic infiltrate, and central necrosis

A

BRCA - Basal like carcinoma

Seems to metastasize very easily 

Tends to be triple negative (ER, PR, HER2)
22
Q

Neoplastic epithelial proliferation limited to ducts/lobules by basement membrane

A

LCIS

23
Q

How does ER/PR/HER2 affect prognosis?

A

ER/PR receptor positive associated with good prognosis because it predicts response to tamoxifen

HER 2 positive associated with bad
prognosis

HER2 mAb - herceptin
Tamoxifen - Oestrogen inhibitor at breast site - oestrogen ↑cancer so inhib is good